Fineline Cube

Follow:
14455 Articles
CompanyDeals

Inmagene Biopharmaceuticals Secures Exclusive License for HutchMed’s Drug Candidates IMG-007 and IMG-004

CompanyLegal / IP

Luye Pharma’s Paliperidone Palmitate NDA Avoids Patent Lawsuit, Clears Path for FDA Approval

CompanyDeals

Matridx Bio Secures Series C+ Funding to Advance Infectious Pathogens Diagnostics

CompanyDeals

China Medical System Reclaims Rights to Velphoro from WinHealth in Greater China

CompanyDrug

Sichuan’s Ancocare Gets FDA Green Light for Phase I/III Study of Oncolytic Virus in Neuroblastoma

Company

Siemens Healthineers Posts 5.7% Q1 2024 Sales Growth, Exceeds Pre-Pandemic Levels

CompanyDrug

Roche Posts Modest 2023 Growth Amid Shifts in Demand for COVID-Related Products

CompanyDeals

Teva Pharmaceuticals Initiates Spin-off of TAPI Unit, Targeting 2025 for Completion

CompanyDrug

Merck KGaA’s Tepmetko Launches in China, Expanding Access to MET Inhibitor for Lung Cancer Patients

CompanyDeals

Chia Tai Tianqing and Fudan University Shanghai Cancer Center Join Forces for Innovative Drug Development

Company

Takeda Secures Rights to Protagonist Therapeutics’ Rusfertide in Landmark Deal

CompanyDrug

Shanghai Junshi Biosciences’ Toripalimab Aims for Singapore Approval in Nasopharyngeal Carcinoma